Joel Sendek - Net Worth and Insider Trading
Joel Sendek Net Worth
The estimated net worth of Joel Sendek is at least $19,963 dollars as of 2024-11-13. Joel Sendek is the CFO of Spero Therapeutics Inc and owns about 15,181 shares of Spero Therapeutics Inc (SPRO) stock worth over $19,963. Details can be seen in Joel Sendek's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Joel Sendek has not made any transactions after 2018-07-05 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Joel Sendek
Joel Sendek Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Joel Sendek owns 1 companies in total, including Spero Therapeutics Inc (SPRO) .
Click here to see the complete history of Joel Sendek’s form 4 insider trades.
Insider Ownership Summary of Joel Sendek
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| SPRO | Spero Therapeutics Inc | 2018-07-05 | Chief Financial Officer |
Joel Sendek Latest Holdings Summary
Joel Sendek currently owns a total of 1 stock. Joel Sendek owns 15,181 shares of Spero Therapeutics Inc (SPRO) as of July 5, 2018, with a value of $19,963.
Latest Holdings of Joel Sendek
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| SPRO | Spero Therapeutics Inc | 2018-07-05 | 15,181 | 1.32 | 19,963 |
Holding Weightings of Joel Sendek
Joel Sendek Form 4 Trading Tracker
According to the SEC Form 4 filings, Joel Sendek has made a total of 0 transactions in Spero Therapeutics Inc (SPRO) over the past 5 years. The most-recent trade in Spero Therapeutics Inc is the sale of 2,000 shares on July 5, 2018, which brought Joel Sendek around $35,000.
Insider Trading History of Joel Sendek
- 1
Joel Sendek Trading Performance
GuruFocus tracks the stock performance after each of Joel Sendek's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Joel Sendek is -0.08%. GuruFocus also compares Joel Sendek's trading performance to market benchmark return within the same time period. The performance of stocks bought by Joel Sendek within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Joel Sendek's insider trading performs compared to the benchmark.
Performance of Joel Sendek
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -4.67 | | | | | |
| Relative Return to S&P 500(%) | -6.14 | | | | | |
Joel Sendek Ownership Network
Ownership Network List of Joel Sendek
Ownership Network Relation of Joel Sendek
Joel Sendek Owned Company Details
What does Spero Therapeutics Inc do?
Who are the key executives at Spero Therapeutics Inc?
Joel Sendek is the Chief Financial Officer of Spero Therapeutics Inc. Other key executives at Spero Therapeutics Inc include Chief Development Officer Timothy Keutzer , director & See Remarks Ankit Mahadevia , and Chief Financial Officer Sath Shukla .
Spero Therapeutics Inc (SPRO) Insider Trades Summary
Over the past 18 months, Joel Sendek made no insider transaction in Spero Therapeutics Inc (SPRO). Other recent insider transactions involving Spero Therapeutics Inc (SPRO) include a net sale of 117,209 shares made by Sath Shukla , a net sale of 78,747 shares made by Ankit Mahadevia , and a net sale of 35,038 shares made by Timothy Keutzer .
In summary, during the past 3 months, insiders sold 10,882 shares of Spero Therapeutics Inc (SPRO) in total and bought 0 shares, with a net sale of 10,882 shares. During the past 18 months, 331,325 shares of Spero Therapeutics Inc (SPRO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 331,325 shares.
Spero Therapeutics Inc (SPRO)'s detailed insider trading history can be found in Insider Trading Tracker table.
Spero Therapeutics Inc Insider Transactions
Joel Sendek Mailing Address
Above is the net worth, insider trading, and ownership report for Joel Sendek. You might contact Joel Sendek via mailing address: C/o Spero Therapeutics, Inc., 675 Massachusetts Avenue, 14th Floor, Cambridge Ma 02139.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
